/ BSX
/ Earnings
Boston Scientific Reports Strong Q3 2025 Results, Raises Full-Year Outlook
Boston Scientific reported Q3 2025 net sales of $5.07 billion and adjusted EPS of $0.75, topping expectations and supporting its upbeat full-year guidance.
October 22, 2025
Boston Scientific (BSX) Beats Q2 Expectations with Strong Growth
Boston Scientific's Q2 2025 results exceeded expectations, with net sales of $5.061 billion and adjusted EPS of $0.75.
July 23, 2025
Boston Scientific Corporation’s Q4 2024 Net Sales Surge by 22.4%, Exceeding Expectations
Boston Scientific Corporation reported robust financial results in Q4 2024, with net sales reaching $4.561 billion, a 22.4% increase from the previous year.
February 05, 2025
BSX Reports $4.12 Billion in Q2 2024 Net Sales, Up 14.5% from Q2 2023
Boston Scientific Corporation (NYSE: BSX) has reported robust financial results for the second quarter of 2024.
July 24, 2024
Boston Scientific (BSX) Beats Expectations with $3.8 Billion in Q1 Net Sales
Boston Scientific Corporation (NYSE: BSX) reported a significant growth in net sales for the first quarter of 2024, reaching $3.856 billion.
April 24, 2024
Back to 
